Mantle Cell Lymphoma

• CLINICAL_TRIALS trial_result · 2011-02-15
  Clinical Trial Update: Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma [Phase 2]

  Phase II study of VcR-CVAD with rituximab consolidation and maintenance for untreated mantle cell lymphoma has completed with results posted…

• CLINICAL_TRIALS trial_result · 2010-07-22
  Clinical Trial Update: Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma [Phase 2]

  The Phase 2 clinical study of SyB L-0501 in patients with indolent B-cell non-Hodgkin's lymphoma and mantle cell lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2010-05-06
  Clinical Trial Update: A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Phase 2]

  Phase 2 study evaluating Lupron Depot to enhance immune function after bone marrow transplantation was terminated, with results posted in 20…

• CLINICAL_TRIALS trial_result · 2009-02-12
  Clinical Trial Update: Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years [Phase 2]

  Completed Phase 2 trial evaluating treatment at diagnosis for mantle cell lymphoma in patients under 65.

• CLINICAL_TRIALS trial_result · 2008-02-11
  Clinical Trial Update: VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]

  This document reports results from a Phase 2 clinical trial of Velcade (bortezomib) in patients with relapsed or refractory mantle cell lymp…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-01-15
  Clinical Trial Update: Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial of elsamitrucin (SPI 28090) for relapsed/refractory non-Hodgkin's lymphoma has completed enrollment/status. The update does no…